Published on
June 3, 2025
- 15:00 GMT
Altis Labs Announces Presentation of Results at ASCO 2025: IPRO-Δ Outperforms RECIST in Predicting OS in Ph 3 Trial
CHICAGO, IL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Altis Labs, Inc. (“Altis”), the computational imaging company accelerating clinical trials with AI, announces the presentation of findings at the American Society of Clinical Oncology (ASCO) …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
